Article
Overexpression of mTOR in Leukocytes from ALS8 Patients.
Current neuropharmacology - 1 Jan 2023
Gomes Nathália Augusta, das Chagas Lima E Silva Francisco, de Oliveira Volpe Caroline Maria, Villar-Delfino Pedro Henrique, de Sousa Camila Ferreira, Rocha-Silva Fabiana, Nogueira-Machado José Augusto
Abstract excerpt
BACKGROUND: The mutated VAPBP56S (vesicle B associated membrane protein - P56S) protein has been described in a Brazilian family and classified as Amyotrophic Lateral Sclerosis type 8 (ALS8). OBJECTIVE: We aimed to study altered biochemical and immunological parameters in cells from ALS8 patients to identify possible biomarkers or therapeutic targets. METHODS: Wild-type VAPB, VAPBP56S, mTOR, proinflammatory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
